John David Auner, MD in Ironton, MO - Family Medicine

John David Auner, MD is a Family Medicine physician based in Ironton, Missouri. John David Auner is licensed to practice in Missouri (license number R5C05) and his current practice location is 128 W Russell St, Ironton, Missouri. He can be reached at his office (for appointments etc.) via phone at (573) 546-3434.

NPI number for John David Auner is 1417050659 and his current mailing address is Po Box 85, Ironton, Missouri. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1417050659.

Contact Information

	John David Auner, MD
	128 W Russell St, Ironton, MO 63650-1313
	(573) 546-3434
	(573) 546-3006

Physician's Profile

Full Name	John David Auner
Gender	Male
Speciality	Family Medicine
Location	128 W Russell St, Ironton, Missouri
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1417050659
Provider Enumeration Date: 09/06/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John David Auner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417050659	NPI	-	NPPES
181408	Other	MO	BLUE CROSS-BLUE SHIELD
178225	Other	MO	HEALTHLINK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	R5C05 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John David Auner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John David Auner, MD Po Box 85, Ironton, MO 63650-0085 Ph: (573) 546-2292	John David Auner, MD 128 W Russell St, Ironton, MO 63650-1313 Ph: (573) 546-3434

News Archive

Walking speed may predict stroke survivor's likelihood of returning to work

A simple walking speed test may help predict whether young adult stroke survivors are ready to return to work, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.

GI Company's Phase II study demonstrates safety of rhITF oral spray formulation

Published today, as an original investigation, in the peer-reviewed Journal of Clinical Oncology, are statistically significant Phase II clinical results of The GI Company's lead clinical compound, rhITF (recombinant human Intestinal Trefoil Factor) oral spray. The article is titled, "A Phase II, Randomized, Double-blind, Placebo-Controlled Study of rhITF Oral Spray for Prevention of Oral Mucositis in Colorectal Cancer Patients Receiving 5-Fluorouracil-based Chemotherapy."

New York Times reports on Gates Foundation's Grand Challenges in Global Health grant program

The New York Times examines the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, which gave a total of $450 million to 43 research projects over five years. "On drawing attention to ways that lives might be saved through scientific advances, I'd give us an A," Bill Gates, co-founder of the foundation, said of the program in an interview with the newspaper. "But I thought some would be saving lives by now, and it'll be more like in 10 years from now," Gates said.

John David Auner, MD - Family Medicine in Ironton, MO